DECOR Information for Project: CDA-CH-VACD - Immunization Content (eVACDOC) (cdachvacd-) |
HTML | Name | Effective Date | Version Label | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Templates with direct association to a transaction | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
Swiss eVACDOC - Immunization Administration | ||||||||||||||
|
||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
Swiss eVACDOC - Immunization Certificate | ||||||||||||||
|
||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
Swiss eVACDOC - Immunization Recommendation Request | ||||||||||||||
|
||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
Swiss eVACDOC - Immunization Recommendation Response | ||||||||||||||
|
||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
Swiss eVACDOC - Vaccination Record | ||||||||||||||
|
||||||||||||||
CDA Document Level Template | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Swiss eVACDOC - Immunization Administration | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Swiss eVACDOC - Immunization Certificate | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Swiss eVACDOC - Immunization Recommendation Request | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Swiss eVACDOC - Immunization Recommendation Response | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Swiss eVACDOC - Vaccination Record | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
CDA Header Level Template | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Information about an authenticator of a CDA document. An authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisa... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑01‑01 20:20:44 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
The organization in whose name this CDA document has been created (corresponds to the sender of a letter). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either refer... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑15 09:26:07 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Information about the person that entered information in this CDA document. It SHALL be declared, when data recorded in this document has been entered by a person other than the author but only when t... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. The LOINC code of the document MUST read: 11369-6 (H... | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
A confidentiality level of a CDA document instance according to the Swiss EPR regulation. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. Langu... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑09‑12 14:08:42 | 2019 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (4) | |||||||||||||
The language in which the narrative texts in this CDA document instance are written. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑09‑12 14:28:13 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2019‑09‑12 14:27:38 | 2019 | |||||||||||
html | ![]() ref
hl7chcda-
|
2019‑09‑12 14:25:02 | 2019 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Swiss Realm (CHE) of HL7 CDA. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Relationship to another CDA-CH V2 based document that is replaced by the current one. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑01‑01 21:22:58 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Unity of document versions. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
CDA-CH V2 bases on HL7 CDA R2 (2005) and - by using this template - require a structured body. All CDA-CH V2 derivatives, i.e. Swiss exchange formats SHALL reference this template. These SHALL define... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑17 15:21:50 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
CDA-CH-VACD V2 bases on CDA-CH V2.1 (2020) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents to be published in the Swiss EPR. | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
CDA-CH-VACD V2 bases on CDA-CH V2.1 (2020) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents that are not to be published in the Swiss EPR. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Information about a health service describing the context of this CDA document. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisation. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑01‑01 20:53:33 | 2019 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
A human patient for whom this CDA document instance was created. | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Information on a patient's insurance. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Information on a patient's insurance card. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Information about the legal authenticator of a CDA document. A legal authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference o... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
A human patient for whom this CDA document instance was created. Its demographic data is masked as much as possible. Only the demographic information (such as gender, birthdate and city) that is neede... | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reference to one or more orders which led to the creation of this CDA document. It SHALL be declared, when the order reference is relevant for some reason. All CDA-CH V2 derivatives, i.e. Swiss exchan... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
A recipient of this CDA document (corresponds to the addressee of a letter - person or organization). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference ... | ||||||||||||||
CDA Section Level Template | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing the active problem list according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain t... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing allergies and other adverse reactions according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (3) | |||||||||||||
Chapter (CDA Body Section) containing the information about a current pregnancy. This section is specialisation of the Pregnancy Hostory section according to IHE PCC Technical Framew... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2018 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing the history of past illness according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains ... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing immunization recommendations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY cont... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing immunizations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains administered i... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
A Laboratory Specialty Section SHALL contain EITHER a list of Laboratory Report Item Section(s) OR a single text and entry element to represent the Report Items. ... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) with laboratory results according to Sharing Laboratory Reports (XD-LAB) Content Module, IHE PaLM Technical Framework Revision 10.0 - August 20, 2019. Each Laboratory Spec... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Chapter (CDA Body Section) containing the coded results according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain relevan... | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
This section MAY be used to provide comments, remarks or other information that cannot be declared in any of the other existing sections in the document. | ||||||||||||||
CDA Entry Level Template | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
This element is a specialization of 'Problem Concern' whereby the problem is focused on an allergy or intolerance. It therefore describes an allergy or intolerances... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Allergies or intolerances are a special form of a 'Problem Entry'. In relation with immunizations, substances in vaccines SHALL be recorded here, using the WHO ATC ... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
This entry allows for a comment to be supplied with each entry. | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
If an examination belongs to a specific case, this CAN be documented with this element (in the Notification Organizer). | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Declaration of analyzer, test kit and manufacturer used to determine the result. All participating elements (including devices), MUST according to XD-LAB contain name, addr and telecom. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2020 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
External documents can be included in a CDA document, either by means of references or by means of XML embedding. This template defines a reference to an external document, only. Embedded documents... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
The coded gestational age in days of gestation at birth of a patient. This item is intended to be applied for the child but not for the mother. | ||||||||||||||
html | ![]() |
2020‑06‑26 | 2020 | |||||||||||
html | ![]() |
2018‑04‑19 | 2018 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
If, in a part of the document, certain laboratory observations for a human patient base on a sample of a non-human material (e.g., food eaten by the patient or an animal that has bitten the patient), ... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑28 13:50:21 | 2014 | |||||||||||
An Antigen Dose entry is used to record additional details about the patient's immunization history. These entries may be used to provide dose details about a specific antigen received during an Immun... | ||||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑01‑08 12:51:58 | 2014 | |||||||||||
The product entry describes a medication or immunization used in a <substanceAdministration> or <supply> act. It adopts the constraints of the ASTM/HL7 Continuity of Care Document. ... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
An immunizations entry is used to record the patient's immunization history. An immunization is a substance administration event. An immunization entry may also be used to report a specific immunizati... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
Health professional that administered the immunization. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
An immunization recommendation entry is used to record the patient's immunization plan. An immunization recommendation is a substance administration proposal or a documentation of an intended, but not... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Immunization Series Number | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2020‑04‑28 10:47:56 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
According to IHE XD-LAB, the Laboratory Battery Organizer allows the grouping of results. Laboratory reports MUST contain at least one result group with at least one result. The grouping of multipl... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
The Laboratory Isolate Organizer MUST ONLY be used if it is a microbiological specimen with which isolates/germs were examined. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Laboratory reports MUST contain at least one laboratory result which is declared using this element. Each laboratory result consists of code, value and interpretation of the result. ... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2020 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
This CAN be used to indicate another executing laboratory in the CDA body. When executing laboratories are specified, the following applies: If all tests have... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Each chapter (Laboratory Speciality Section and Laboratory Report Item Section) MUST contain exactly one findings group (CDA Body Laboratory Report Data Processing Entry). | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
The document MAY contain further signatures (besides the legal authenticator). A Laboratory Results Validator is such an authenticator. It is a laboratory specialist who has performe... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Structured information on a product (e.g. Vaccine or Medication). Trade name of the product SHALL be present in the element 'name' of manufact... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Multimedia objects (e.g., PDF representations of the CDA document, pictures, Reiber diagrams, electrophoresis, etc.) MAY be integrated into a CDA document, either by reference to ext... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2020 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
If, in a part of the document, laboratory obseravtions base exclusively on a sample of a non-human material (e.g., animal, water, soil, etc.) without reference to a patient, it MUST be declared using... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
If a reportable condition is given (e.g., according to the Federal Act on Combating Communicable Human Diseases and the associated ordinance), this CAN be declared in the CDA body using this element. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
A laboratory report MAY contain information on the obligation to report pathogen detection, on accumulation of observations or specific epidemiologically relevant events. ... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
If an examination falls under the category "accumulation of observations" or "specific epidemiologically relevant event", this CAN be declared in the CDA body using this element. ... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
This element contains structured information about the delivery date of a pregnancy. | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2018 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
This element contains structured information about a pregnancy. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
A laboratory result can be supplemented with any number of previous results, if this information is important. Previous laboratory results MUST be associated to the same patient, the same test, the sa... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
This element describes a problem concern of the patient and indicates the period of time where this concern is active. It contains a set of references to problems related to this concern. In the conte... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Problem as structured entry (e.g. syptom, complaint, diagnosis etc.) | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Any problem or allergy observation may reference a problem status observation. | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reaction as structured entry | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2020‑04‑29 12:47:35 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2018‑04‑19 | 2018 | |||||||||||
Recommendation category according to the Swiss vaccination plan. | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
External laboratory that has delivered the results. The following applies: The external laboratory MUST be declared, including its responsible person. All... | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Declaration of the severity of a problem or an allergy/intolerance | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2016 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2016 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Laboratory reports MAY contain information on the specimen. If there are more than one specimen associated to the order, then this item occurs multiple times. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Specimen Information. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
A laboratory report MAY contain information on the reception of the specimen at the laboratory. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2019 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Specimen Type. | ||||||||||||||
html | ![]() ref
ch-palm-
|
2019‑08‑20 | 2020 | |||||||||||
html | ![]() ref
ch-palm-
|
2017‑06‑21 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Target of the immunization. All immunizations targets (diseases) SHALL be recorded with an immunization entry. This element allows structured information for immunizations with combinded vaccines (e.g... | ||||||||||||||
html | ![]() ref
ch-pcc-
|
2018‑04‑19 | 2018 | |||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑12 | 2018 | |||||||||||
Template type not specified | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Address information according to the eCH-0010 V7.0 addressInformation data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. See h... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an assigned entity with a required GLN is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or speci... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:53:35 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an assigned entity with required GLN, name, addr, telecom, person and organization (also with GLN) are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchan... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:50:31 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an assigned entity with a required id is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:41:55 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an assigned entity with required id, name, addr, telecom, person and organization are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY us... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:38:14 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an assigned entity with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either r... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:20:55 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Information about the author of a CDA document, section or entry. An author MAY be a person or a device. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template at least in the C... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑09‑12 13:48:28 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2020‑04‑28 12:02:52 | 2020 | |||||||||||
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an author with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 15:57:29 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2019‑10‑24 16:13:06 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever a device with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever a text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MA... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever an organization with required GLN as id and name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either referenc... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever an organization with required GLN as id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use th... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever an organization with required id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this temp... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever an organization with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialis... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever an organization with required name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever a original text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange f... | ||||||||||||||
![]() |
Multiple (2) | |||||||||||||
Reusable template wherever a healthcare provider who was the primary performer of an act is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by ei... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑12‑24 19:51:04 | 2020 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Person name information (with required family and given name) according to the eCH-0011 V8.1 nameData data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either ref... | ||||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||||
Reusable template wherever a playing entity with a required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia... |
Templates | 168 |
Transaction | Representing template | Link | as of |
---|---|---|---|
CDA-CH-VACD - Immunization Administration | 2.16.756.5.30.1.1.10.1.16 | Immunization Administration | 2020‑06‑26 |
CDA-CH-VACD - Immunization Certificate | 2.16.756.5.30.1.1.10.1.15 | Immunization Certificate | 2020‑06‑26 |
CDA-CH-VACD - Immunization Recommendation Request | 2.16.756.5.30.1.1.10.1.17 | Immunization Recommendation Request | 2020‑06‑26 |
CDA-CH-VACD - Immunization Recommendation Response | 2.16.756.5.30.1.1.10.1.18 | Immunization Recommendation Response | 2020‑06‑26 |
CDA-CH-VACD - Vaccination Record | 2.16.756.5.30.1.1.10.1.19 | Vaccination Record | 2020‑06‑26 |
Label | Template id | Template name | Link | as of | |
---|---|---|---|---|---|
6.3.4.19 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.51 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12.1 | IHE Antigen Dose entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12.1 | 2016‑09‑28 13:50:21 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.13 | Document Replacement - relatedDocument | 2.16.756.5.30.1.1.10.2.13 | 2019‑01‑01 21:22:58 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.13 | Document Replacement - relatedDocument | 2.16.756.5.30.1.1.10.2.13 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.14 | Insurance Card - participant | 2.16.756.5.30.1.1.10.2.14 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.15 | Insurance - participant | 2.16.756.5.30.1.1.10.2.15 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.16 | Order Reference - inFulfillmentOf | 2.16.756.5.30.1.1.10.2.16 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.18 | Document Template Ids CDA-CH v2.0 - structuredBody | 2.16.756.5.30.1.1.10.2.18 | 2019‑10‑17 15:21:50 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.18 | Document Template Ids CDA-CH v2.0 - structuredBody | 2.16.756.5.30.1.1.10.2.18 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.19 | Document Confidentiality Code | 2.16.756.5.30.1.1.10.2.19 | 2019‑09‑12 14:08:42 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.19 | Document Confidentiality Code | 2.16.756.5.30.1.1.10.2.19 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.20 | Document Set Id and Version Number | 2.16.756.5.30.1.1.10.2.20 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.22 | Document Language | 2.16.756.5.30.1.1.10.2.22 | 2019‑09‑12 14:28:13 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.22 | Document Language | 2.16.756.5.30.1.1.10.2.22 | 2019‑09‑12 14:27:38 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.22 | Document Language | 2.16.756.5.30.1.1.10.2.22 | 2019‑09‑12 14:25:02 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.22 | Document Language | 2.16.756.5.30.1.1.10.2.22 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.25 | Document Realm | 2.16.756.5.30.1.1.10.2.25 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.3 | Custodian | 2.16.756.5.30.1.1.10.2.3 | 2019‑10‑15 09:26:07 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.3 | Custodian | 2.16.756.5.30.1.1.10.2.3 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.4 | Recipient - informationRecipient | 2.16.756.5.30.1.1.10.2.4 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.46 | Health Service - documentationOf | 2.16.756.5.30.1.1.10.2.46 | 2019‑01‑01 20:53:33 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.46 | Health Service - documentationOf | 2.16.756.5.30.1.1.10.2.46 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.5 | Legal Authenticator | 2.16.756.5.30.1.1.10.2.5 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.6 | Authenticator | 2.16.756.5.30.1.1.10.2.6 | 2019‑01‑01 20:20:44 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.6 | Authenticator | 2.16.756.5.30.1.1.10.2.6 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.2.7 | Data Enterer | 2.16.756.5.30.1.1.10.2.7 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.3.2 | Remarks Section - coded | 2.16.756.5.30.1.1.10.3.2 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.4.29 | External document | 2.16.756.5.30.1.1.10.4.29 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.12 | Assigned Entity Compilation with id | 2.16.756.5.30.1.1.10.9.12 | 2019‑10‑24 16:41:55 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.12 | Assigned Entity Compilation with id | 2.16.756.5.30.1.1.10.9.12 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.14 | Narrative Text Reference | 2.16.756.5.30.1.1.10.9.14 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.16 | Author Compilation with name, addr and telecom | 2.16.756.5.30.1.1.10.9.16 | 2019‑10‑24 16:13:06 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.16 | Author Compilation with name, addr and telecom | 2.16.756.5.30.1.1.10.9.16 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.17 | Assigned Entity Compilation with name, addr and telecom | 2.16.756.5.30.1.1.10.9.17 | 2019‑10‑24 16:20:55 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.17 | Assigned Entity Compilation with name, addr and telecom | 2.16.756.5.30.1.1.10.9.17 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.20 | PlayingEntity Compilation with name | 2.16.756.5.30.1.1.10.9.20 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.21 | Device Compilation with name | 2.16.756.5.30.1.1.10.9.21 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.23 | Author | 2.16.756.5.30.1.1.10.9.23 | 2019‑09‑12 13:48:28 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.23 | Author | 2.16.756.5.30.1.1.10.9.23 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.24 | Organization Compilation with name | 2.16.756.5.30.1.1.10.9.24 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.26 | Organization Compilation with GLN, name, addr and telecom | 2.16.756.5.30.1.1.10.9.26 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.27 | Organization Compilation with name, addr, telecom | 2.16.756.5.30.1.1.10.9.27 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.30 | Organization Compilation with GLN and name | 2.16.756.5.30.1.1.10.9.30 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.32 | Assigned Entity Compilation with id, name, addr, telecom, person and organization | 2.16.756.5.30.1.1.10.9.32 | 2019‑10‑24 16:38:14 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.32 | Assigned Entity Compilation with id, name, addr, telecom, person and organization | 2.16.756.5.30.1.1.10.9.32 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.33 | Organization Compilation with id, name, addr and telecom | 2.16.756.5.30.1.1.10.9.33 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.48 | Author Compilation with name | 2.16.756.5.30.1.1.10.9.48 | 2019‑10‑24 15:57:29 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.48 | Author Compilation with name | 2.16.756.5.30.1.1.10.9.48 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.49 | Original Text Reference | 2.16.756.5.30.1.1.10.9.49 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.50 | Assigned Entity Compilation with GLN, name, addr, telecom, person and organization | 2.16.756.5.30.1.1.10.9.50 | 2019‑10‑24 16:50:31 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.50 | Assigned Entity Compilation with GLN, name, addr, telecom, person and organization | 2.16.756.5.30.1.1.10.9.50 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.51 | Assigned Entity Compilation with GLN and name | 2.16.756.5.30.1.1.10.9.51 | 2019‑10‑24 16:53:35 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.51 | Assigned Entity Compilation with GLN and name | 2.16.756.5.30.1.1.10.9.51 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
2.16.756.5.30.1.1.10.9.54 | Author Compilation with id, name, addr and telecom | 2.16.756.5.30.1.1.10.9.54 | 2020‑04‑28 12:02:52 |
CDA‑CH V2 Body Templates | ![]() |
2.16.756.5.30.1.1.10.3.53 | Current Pregnancy Section - coded | 2.16.756.5.30.1.1.10.3.53 | 2018‑04‑19 |
CDA‑CH V2 Body Templates | ![]() |
2.16.756.5.30.1.1.10.3.53 | Current Pregnancy Section - coded | 2.16.756.5.30.1.1.10.3.53 | 2016‑11‑12 |
CDA‑CH V2 Body Templates | ![]() |
2.16.756.5.30.1.1.10.3.53 | Current Pregnancy Section - coded | 2.16.756.5.30.1.1.10.3.53 | 2016‑11‑11 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.67 | Document Template Ids CDA-CH-VACD V2 for Swiss EPR | 2.16.756.5.30.1.1.10.2.67 | 2020‑06‑26 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.68 | Human Patient - recordTarget | 2.16.756.5.30.1.1.10.2.68 | 2020‑06‑26 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.68 | Human Patient - recordTarget | 2.16.756.5.30.1.1.10.2.68 | 2018‑04‑19 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.69 | Masked Patient - recordTarget | 2.16.756.5.30.1.1.10.2.69 | 2020‑06‑26 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.69 | Masked Patient - recordTarget | 2.16.756.5.30.1.1.10.2.69 | 2018‑04‑19 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.2.71 | Document Template Ids CDA-CH-VACD V2 non Swiss EPR | 2.16.756.5.30.1.1.10.2.71 | 2020‑06‑26 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.4.101 | Immunization Performer - performer Containment | 2.16.756.5.30.1.1.10.4.101 | 2016‑11‑11 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.4.95 | Target Of The Immunization - Medication Target | 2.16.756.5.30.1.1.10.4.95 | 2018‑04‑19 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.4.95 | Target Of The Immunization - Medication Target | 2.16.756.5.30.1.1.10.4.95 | 2016‑11‑12 |
CDA‑CH‑VACD | ![]() |
2.16.756.5.30.1.1.10.4.96 | Recommendation Category - Criterion | 2.16.756.5.30.1.1.10.4.96 | 2018‑04‑19 |
CDA‑CH‑VACVD | ![]() |
2.16.756.5.30.1.1.10.4.84 | Gestational Age At Birth | 2.16.756.5.30.1.1.10.4.84 | 2020‑06‑26 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.10 | Device - participant Containment | 2.16.756.5.30.1.1.10.4.10 | 2019‑08‑20 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.10 | Device - participant Containment | 2.16.756.5.30.1.1.10.4.10 | 2017‑06‑21 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.18 | Multimedia Embedded Content | 2.16.756.5.30.1.1.10.4.18 | 2019‑08‑20 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.18 | Multimedia Embedded Content | 2.16.756.5.30.1.1.10.4.18 | 2017‑06‑21 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.27 | Specimen Type | 2.16.756.5.30.1.1.10.4.27 | 2019‑08‑20 |
CH‑PALM | ![]() |
2.16.756.5.30.1.1.10.4.27 | Specimen Type | 2.16.756.5.30.1.1.10.4.27 | 2017‑06‑21 |
CH‑PCC | ![]() |
2.16.756.5.30.1.1.10.4.102 | Pregnancy Observation Delivery Date | 2.16.756.5.30.1.1.10.4.102 | 2018‑04‑19 |
CH‑PCC | ![]() |
2.16.756.5.30.1.1.10.4.102 | Pregnancy Observation Delivery Date | 2.16.756.5.30.1.1.10.4.102 | 2016‑11‑12 |
CH‑PCC | ![]() |
2.16.756.5.30.1.1.10.4.84 | Gestational Age At Birth | 2.16.756.5.30.1.1.10.4.84 | 2018‑04‑19 |
IHE PCC TF2 Rev.11, 6.3.1.10.1 | ![]() |
2.16.756.5.30.1.1.10.2.63 | Document Code | 2.16.756.5.30.1.1.10.2.63 | 2020‑06‑26 |
IHE PCC TF2 Rev.11, 6.3.1.10.1 | ![]() |
2.16.756.5.30.1.1.10.2.63 | Document Code | 2.16.756.5.30.1.1.10.2.63 | 2018‑04‑19 |
IHE PCC TF2 Rev.11, 6.3.3.2.11 | ![]() |
2.16.756.5.30.1.1.10.3.51 | Allergies and other Adverse Reactions Section - coded | 2.16.756.5.30.1.1.10.3.51 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.3.2.11 | ![]() |
2.16.756.5.30.1.1.10.3.51 | Allergies and other Adverse Reactions Section - coded | 2.16.756.5.30.1.1.10.3.51 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.3.2.3 | ![]() |
2.16.756.5.30.1.1.10.3.25 | Active Problems Section - coded | 2.16.756.5.30.1.1.10.3.25 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.3.2.3 | ![]() |
2.16.756.5.30.1.1.10.3.25 | Active Problems Section - coded | 2.16.756.5.30.1.1.10.3.25 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.3.2.5 | ![]() |
2.16.756.5.30.1.1.10.3.50 | History Of Past Illness Section - coded | 2.16.756.5.30.1.1.10.3.50 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.3.2.5 | ![]() |
2.16.756.5.30.1.1.10.3.50 | History Of Past Illness Section - coded | 2.16.756.5.30.1.1.10.3.50 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.3.3.5 | ![]() |
2.16.756.5.30.1.1.10.3.47 | Immunizations Section - coded | 2.16.756.5.30.1.1.10.3.47 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.3.3.5 | ![]() |
2.16.756.5.30.1.1.10.3.47 | Immunizations Section - coded | 2.16.756.5.30.1.1.10.3.47 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.3.5.2 | ![]() |
2.16.756.5.30.1.1.10.3.46 | Other Relevant Observations Section - coded | 2.16.756.5.30.1.1.10.3.46 | 2020‑06‑26 |
IHE PCC TF2 Rev.11, 6.3.3.5.2 | ![]() |
2.16.756.5.30.1.1.10.3.46 | Other Relevant Observations Section - coded | 2.16.756.5.30.1.1.10.3.46 | 2018‑04‑19 |
IHE PCC TF2 Rev.11, 6.3.3.6.13 | ![]() |
2.16.756.5.30.1.1.10.3.48 | Immunization Recommendations Section - coded | 2.16.756.5.30.1.1.10.3.48 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.3.6.13 | ![]() |
2.16.756.5.30.1.1.10.3.48 | Immunization Recommendations Section - coded | 2.16.756.5.30.1.1.10.3.48 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.12 | ![]() |
2.16.756.5.30.1.1.10.4.90 | Problem Concern Entry | 2.16.756.5.30.1.1.10.4.90 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.12 | ![]() |
2.16.756.5.30.1.1.10.4.90 | Problem Concern Entry | 2.16.756.5.30.1.1.10.4.90 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.91 | Allergies and Intolerances Concern Entry | 2.16.756.5.30.1.1.10.4.91 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.91 | Allergies and Intolerances Concern Entry | 2.16.756.5.30.1.1.10.4.91 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.14 | ![]() |
2.16.756.5.30.1.1.10.4.97 | Problem Entry | 2.16.756.5.30.1.1.10.4.97 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.14 | ![]() |
2.16.756.5.30.1.1.10.4.97 | Problem Entry | 2.16.756.5.30.1.1.10.4.97 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.15 | ![]() |
2.16.756.5.30.1.1.10.4.98 | Allergy Or Intolerance Entry | 2.16.756.5.30.1.1.10.4.98 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.15 | ![]() |
2.16.756.5.30.1.1.10.4.98 | Allergy Or Intolerance Entry | 2.16.756.5.30.1.1.10.4.98 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.15.10 | ![]() |
2.16.756.5.30.1.1.10.4.120 | Reaction Observation | 2.16.756.5.30.1.1.10.4.120 | 2020‑04‑29 12:47:35 |
IHE PCC TF2 Rev.11, 6.3.4.15.10 | ![]() |
2.16.756.5.30.1.1.10.4.120 | Reaction Observation | 2.16.756.5.30.1.1.10.4.120 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.17 | ![]() |
2.16.756.5.30.1.1.10.4.89 | Immunization Entry | 2.16.756.5.30.1.1.10.4.89 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.17 | ![]() |
2.16.756.5.30.1.1.10.4.89 | Immunization Entry | 2.16.756.5.30.1.1.10.4.89 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.19 | ![]() |
2.16.756.5.30.1.1.10.4.94 | Manufactured Product | 2.16.756.5.30.1.1.10.4.94 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.19 | ![]() |
2.16.756.5.30.1.1.10.4.94 | Manufactured Product | 2.16.756.5.30.1.1.10.4.94 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.25 | ![]() |
2.16.756.5.30.1.1.10.4.92 | Pregnancy Observation Entry | 2.16.756.5.30.1.1.10.4.92 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.3 | ![]() |
2.16.756.5.30.1.1.10.4.99 | Severity Entry | 2.16.756.5.30.1.1.10.4.99 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.3 | ![]() |
2.16.756.5.30.1.1.10.4.99 | Severity Entry | 2.16.756.5.30.1.1.10.4.99 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.4 | ![]() |
2.16.756.5.30.1.1.10.4.100 | Problem Status Observation | 2.16.756.5.30.1.1.10.4.100 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.4 | ![]() |
2.16.756.5.30.1.1.10.4.100 | Problem Status Observation | 2.16.756.5.30.1.1.10.4.100 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.49 | ![]() |
2.16.756.5.30.1.1.10.4.93 | Immunization Recommendation Entry | 2.16.756.5.30.1.1.10.4.93 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.49 | ![]() |
2.16.756.5.30.1.1.10.4.93 | Immunization Recommendation Entry | 2.16.756.5.30.1.1.10.4.93 | 2016‑11‑11 |
IHE PCC TF2 Rev.11, 6.3.4.49.11 | ![]() |
2.16.756.5.30.1.1.10.4.119 | Immunization Series Number | 2.16.756.5.30.1.1.10.4.119 | 2020‑04‑28 10:47:56 |
IHE PCC TF2 Rev.11, 6.3.4.49.11 | ![]() |
2.16.756.5.30.1.1.10.4.119 | Immunization Series Number | 2.16.756.5.30.1.1.10.4.119 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.6 | ![]() |
2.16.756.5.30.1.1.10.4.2 | Annotation Comments | 2.16.756.5.30.1.1.10.4.2 | 2016‑11‑12 |
IHE PCC TF2 Rev.11, 6.3.4.6 | ![]() |
2.16.756.5.30.1.1.10.4.2 | Annotation Comments | 2.16.756.5.30.1.1.10.4.2 | 2016‑11‑11 |
IHE PalM TF3 Rev.10, 6.3.2.16 | ![]() |
2.16.756.5.30.1.1.10.4.8 | Laboratory Results Validator - participant Containment | 2.16.756.5.30.1.1.10.4.8 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.2.20 | ![]() |
2.16.756.5.30.1.1.10.4.7 | Laboratory Performer - performer Containment | 2.16.756.5.30.1.1.10.4.7 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.3.1 | ![]() |
2.16.756.5.30.1.1.10.3.3 | Laboratory Speciality Section - coded | 2.16.756.5.30.1.1.10.3.3 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.3.2 | ![]() |
2.16.756.5.30.1.1.10.3.5 | Laboratory Report Item Section - coded | 2.16.756.5.30.1.1.10.3.5 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.10 | ![]() |
2.16.756.5.30.1.1.10.4.16 | Outbreak Identification | 2.16.756.5.30.1.1.10.4.16 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.11 | ![]() |
2.16.756.5.30.1.1.10.4.17 | Laboratory Isolate Organizer | 2.16.756.5.30.1.1.10.4.17 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.12 | ![]() |
2.16.756.5.30.1.1.10.4.19 | Laboratory Battery Organizer | 2.16.756.5.30.1.1.10.4.19 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.22 | Previous Observation | 2.16.756.5.30.1.1.10.4.22 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.3 | Laboratory Observation | 2.16.756.5.30.1.1.10.4.3 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.16 | ![]() |
2.16.756.5.30.1.1.10.4.9 | Responsible Party - participant Containment | 2.16.756.5.30.1.1.10.4.9 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.2 | ![]() |
2.16.756.5.30.1.1.10.4.4 | Laboratory Report Data Processing Entry | 2.16.756.5.30.1.1.10.4.4 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.3 | ![]() |
2.16.756.5.30.1.1.10.4.5 | Non-Human Subject - subject Containment | 2.16.756.5.30.1.1.10.4.5 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.4 | ![]() |
2.16.756.5.30.1.1.10.4.6 | Human Patient with Non-Human Subject - subject Containment | 2.16.756.5.30.1.1.10.4.6 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.5 | ![]() |
2.16.756.5.30.1.1.10.4.11 | Specimen Collection | 2.16.756.5.30.1.1.10.4.11 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.5 | ![]() |
2.16.756.5.30.1.1.10.4.24 | Specimen collection - participant Containment | 2.16.756.5.30.1.1.10.4.24 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.6 | ![]() |
2.16.756.5.30.1.1.10.4.12 | Specimen Received | 2.16.756.5.30.1.1.10.4.12 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.7 | ![]() |
2.16.756.5.30.1.1.10.4.13 | Notification Organizer | 2.16.756.5.30.1.1.10.4.13 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.8 | ![]() |
2.16.756.5.30.1.1.10.4.14 | Notifiable Condition | 2.16.756.5.30.1.1.10.4.14 | 2019‑08‑20 |
IHE PalM TF3 Rev.10, 6.3.4.9 | ![]() |
2.16.756.5.30.1.1.10.4.15 | Case Identification | 2.16.756.5.30.1.1.10.4.15 | 2019‑08‑20 |
IHE PalM TF3 Rev.8 | ![]() |
2.16.756.5.30.1.1.10.4.9 | Responsible Party - participant Containment | 2.16.756.5.30.1.1.10.4.9 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.2.16 | ![]() |
2.16.756.5.30.1.1.10.4.8 | Laboratory Results Validator - authenticator/participant Containment | 2.16.756.5.30.1.1.10.4.8 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.2.20 | ![]() |
2.16.756.5.30.1.1.10.4.7 | Laboratory Performer - performer Containment | 2.16.756.5.30.1.1.10.4.7 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.3.1 | ![]() |
2.16.756.5.30.1.1.10.3.3 | Laboratory Speciality Section - coded | 2.16.756.5.30.1.1.10.3.3 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.3.2 | ![]() |
2.16.756.5.30.1.1.10.3.5 | Laboratory Report Item Section - coded | 2.16.756.5.30.1.1.10.3.5 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.10 | ![]() |
2.16.756.5.30.1.1.10.4.16 | Outbreak Identification | 2.16.756.5.30.1.1.10.4.16 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.11 | ![]() |
2.16.756.5.30.1.1.10.4.17 | Laboratory Isolate Organizer | 2.16.756.5.30.1.1.10.4.17 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.12 | ![]() |
2.16.756.5.30.1.1.10.4.19 | Laboratory Battery Organizer | 2.16.756.5.30.1.1.10.4.19 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.22 | Previous Observation | 2.16.756.5.30.1.1.10.4.22 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.13 | ![]() |
2.16.756.5.30.1.1.10.4.3 | Laboratory Observation | 2.16.756.5.30.1.1.10.4.3 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.2 | ![]() |
2.16.756.5.30.1.1.10.4.4 | Laboratory Report Data Processing Entry | 2.16.756.5.30.1.1.10.4.4 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.3 | ![]() |
2.16.756.5.30.1.1.10.4.5 | Non-Human Subject - subject Containment | 2.16.756.5.30.1.1.10.4.5 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.4 | ![]() |
2.16.756.5.30.1.1.10.4.6 | Human Patient with Non-Human Subject - subject Containment | 2.16.756.5.30.1.1.10.4.6 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.5 | ![]() |
2.16.756.5.30.1.1.10.4.11 | Specimen Collection | 2.16.756.5.30.1.1.10.4.11 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.5 | ![]() |
2.16.756.5.30.1.1.10.4.24 | Specimen collection - participant Containment | 2.16.756.5.30.1.1.10.4.24 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.6 | ![]() |
2.16.756.5.30.1.1.10.4.12 | Specimen Received | 2.16.756.5.30.1.1.10.4.12 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.7 | ![]() |
2.16.756.5.30.1.1.10.4.13 | Notification Organizer | 2.16.756.5.30.1.1.10.4.13 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.8 | ![]() |
2.16.756.5.30.1.1.10.4.14 | Notifiable Condition | 2.16.756.5.30.1.1.10.4.14 | 2017‑06‑21 |
IHE PalM TF3 Rev.8, 6.3.4.9 | ![]() |
2.16.756.5.30.1.1.10.4.15 | Case Identification | 2.16.756.5.30.1.1.10.4.15 | 2017‑06‑21 |
eCH‑0010 V7.0 addressInformation | ![]() |
2.16.756.5.30.1.1.10.9.35 | Address Information Compilation - eCH-0010 | 2.16.756.5.30.1.1.10.9.35 | 2018‑04‑18 |
eCH‑0011 V8.1 nameData | ![]() |
2.16.756.5.30.1.1.10.9.34 | Person Name Information Compilation - eCH-0011 | 2.16.756.5.30.1.1.10.9.34 | 2018‑04‑18 |
Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.